Home > Healthcare > Biotechnology > Bioservices > Biobanking Market

Biobanking Market Share

Report ID: GMI6534
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Biobanking Market Share

The prominent players in biobanking market are

Thermo Fisher Scientific, Inc.
PHC Holdings Corporation
Hamilton Company
Avantor Inc.
Qiagen N.V.
Tecan Trading AG
Merck & Co., Inc.
Becton
Dickinson and Company
Cryoport Inc.
Azenta Inc.

These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The biobanking industry size was USD 62.6 billion in 2022 and is predicted to experience a sustainable growth of CAGR 7.2% from 2023 to 2032.

The equipment segment accounted for the largest market share of 52.4% in 2022 and is expected to record around 7.3% CAGR from 2023 to 2032 attributed to the rapid increase in the number of new biobanks.

North America biobanking market size was around USD 20.2 billion, and it is expected to reach USD 41.5 billion by 2032 attributed to factors such as robust & well-established research infrastructure, with numerous renowned academic and research institutions.

Thermo Fisher Scientific, Inc., PHC Holdings Corporation, Hamilton Company, Avantor Inc., Qiagen N.V., Tecan Trading AG, Merck & Co., Inc., Becton, Dickinson and Company, Cryoport Inc., and Azenta Inc.